Autor: |
Hajdú I; Institute of Enzymology, Research Centre for Natural Sciences, 1117 Budapest, Hungary., Végh BM; Institute of Enzymology, Research Centre for Natural Sciences, 1117 Budapest, Hungary., Szilágyi A; Institute of Enzymology, Research Centre for Natural Sciences, 1117 Budapest, Hungary., Závodszky P; Institute of Enzymology, Research Centre for Natural Sciences, 1117 Budapest, Hungary.; Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, 1083 Budapest, Hungary. |
Jazyk: |
angličtina |
Zdroj: |
International journal of molecular sciences [Int J Mol Sci] 2023 Jun 21; Vol. 24 (13). Date of Electronic Publication: 2023 Jun 21. |
DOI: |
10.3390/ijms241310416 |
Abstrakt: |
The amyloidogenic processing of APP depends on two events: its phosphorylation by ROCK2 (at Thr654) and the phosphorylation of the APP-cleaving enzyme BACE1 (at Ser498). However, the mechanisms and structural details of APP-ROCK2 and BACE1-ROCK2 binding are unknown. Using direct physical methods in combination with an in silico approach, we found that BACE1 binds into the substrate-binding groove of ROCK2 with a low affinity (K d = 18 µM), while no binding of APP to ROCK2 alone could be detected. On the other hand, a strong association (K d = 3.5 nM) of APP to the weak ROCK2-BACE1 complex was observed, although no stable ternary complex was detected, i.e., BACE1 was displaced by APP. We constructed a sequential functional model: (1) BACE1 weakly binds to ROCK2 and induces an allosteric conformational change in ROCK2; (2) APP strongly binds to the ROCK2-BACE1 complex, and BACE1 is released; and (3) ROCK2 phosphorylates APP at Thr654 (leading to a longer stay in the early endosome during APP processing). Direct fluorescence titration experiments showed that the APP 646-664 or APP 665-695 fragments did not bind separately to the ROCK2-BACE1 complex. Based on these observations, we conclude that two binding sites are involved in the ROCK2-APP interaction: (1) the substrate-binding groove, where the APP 646-664 sequence containing Thr654 sits and (2) the allosteric binding site, where the APP 665-695 sequence binds. These results open the way to attack the allosteric site to prevent APP phosphorylation at Thr654 by ROCK2 without inhibiting the activity of ROCK2 towards its other substrates. |
Databáze: |
MEDLINE |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|